Identification of Miscellaneous Peptides from the Skin Secretion of the European Edible Frog, Pelophylax kl. Esculentus by Chen, Xiaole et al.
Identification of Miscellaneous Peptides from the Skin Secretion of the
European Edible Frog, Pelophylax kl. Esculentus
Chen, X., Wang, H., Wang, L., Zhou, M., Chen, T., & Shaw, C. (2016). Identification of Miscellaneous Peptides
from the Skin Secretion of the European Edible Frog, Pelophylax kl. Esculentus. The Protein Journal, 35(4), 291-
299. DOI: 10.1007/s10930-016-9672-z
Published in:
The Protein Journal
Document Version:
Peer reviewed version
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
© Springer Science+Business Media New York 2016
The final publication is available at Springer via http://link.springer.com/article/10.1007%2Fs10930-016-9672-z
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:06. Nov. 2017
 1 
 
 
 
 
Identification of miscellaneous peptides from the skin secretion of the European edible 
frog, Pelophylax kl. Esculentus 
Xiaole Chen 1,*, He Wang 2,*, Lei Wang 3, Mei Zhou 3, Tianbao Chen 3, Chris Shaw 3 
 
1. School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China 
2. School of Integrative Medicine, Fujian University of Traditional Chinese Medicine, China 
3. Medicine Natural peptide discovery group, School of Pharmacy, Queen’s University, Belfast BT9 7BL, 
Northern Ireland, UK 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Corresponding author.  Tel: +86(0)59122862016; Fax:+86(0)59122862016 
E-mail address: leochen5139@fjmu.edu.cn (Xiaole Chen); hwang11@qub.ac.uk (He Wang) 
 2 
 
Abstract 
The chemical compounds synthesised and secreted from the dermal glands of amphibian have diverse 
bioactivities that play key roles in the hosts’ innate immune system and in causing diverse pharmacological 
effects in predators that may ingest the defensive skin secretions.  As new biotechnological methods have 
developed, increasing numbers of novel peptides with novel activities have been discovered from this source of 
natural compounds. In this study, a number of defensive skin secretion peptide sequences were obtained from 
the European edible frog, P. kl. esculentus, using a ‘shotgun’ cloning technique developed previously within our 
laboratory. Some of these sequences have been previously reported but had either obtained from other species or 
were isolated using different methods. Two new skin peptides are described here for the first time. Esculentin-2c 
and Brevinin-2Tbe belong to the Esculentin-2 and Brevinin-2 families, respectively, and both are very similar to 
their respective analogues but with a few amino acid differences. Further, [Asn-3, Lys-6, Phe-13] 3-14 
bombesin isolated previously from the skin of the marsh frog, Rana ridibunda, was identified here in the skin of 
P. kl. esculentus. Studies such as this can provide a rapid elucidation of peptide and corresponding DNA 
sequences from unstudied species of frogs and can rapidly provide a basis for related scientific studies such as 
those involved in systematic or the evolution of a large diverse gene family and usage by biomedical researchers 
as a source of potential novel drug leads or pharmacological agents. 
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1. Introduction 
Amphibian skin glands produce complex mixtures of bioactive compounds that have been used in 
traditional and folk medicines around the world for centuries. In modern times, it has become apparent that 
amphibians, whose living environments are full of various kinds of microorganisms, have developed a unique 
survival strategy for protecting themselves against potential pathogens. These highly-efficient host-defence 
compounds that are secreted from the skins of amphibians are attracting ever-increasing scientific attention, as it 
seems that they may be good templates for the development of new antibiotics designed to combat the 
emergence of pathogens that are resistant to conventional antibiotics. As many studies have shown, amphibian 
skin secretions not only produce potent broad-spectrum antimicrobial peptides, but also a number of peptides 
that have very similar structures and biological activities to mammalian neuropeptides and hormones, such as 
the bombesins, bradykinins and tachykinins [1-2]. In early research, hundreds or even thousands of amphibians 
were sacrificed to obtain enough material for biological and chemical analyses, though as modern methods and 
technologies have developed, this killing has become unnecessary. A good example of this advanced practice 
can be found in the mild electrical stimulation method that releases the secretions of the granular skin glands 
without damaging the host.  This technique continues to play a key role in isolating and identifying the active 
peptides contained in skin secretions and in preservation of endangered species [1-3]. 
Members of the family Ranidae are widely distributed in Europe, Asia and North America, with an 
estimated 250 different species producing a large number of diverse antimicrobial peptides, more than 400 of 
which have been isolated so far [4-5]. Compared with the antimicrobial peptides isolated from other species that 
often contain a C-terminal amide, the peptides from ranid frog skin secretions are normally of 10-47 amino acid 
residues with a 6-9-membered cyclic loop region with a single disulfide bridge, called the Rana box, at the C-
terminus [2, 6]. Based on the similarities of sequences between individual peptides, these can be classified into 
13 peptide families comprising: brevinin-1s, brevinin-2s, esculentin-1s, esculentin-2s, japonicin-2s, nigrocin-2s, 
palustrin-1s, palustrin-2s, ranacyclins, ranatuerin-1s, ranatuerin-2s, and temporins.  Generally, ranid frog 
antimicrobial peptides are cationic and adopt amphipathic α-helical structures in order to readily bind to 
bacterial cell membranes through which they induce cell lysis [7]. 
Esculentin-related peptides are regarded as the earliest characterised family and are the largest skin 
antimicrobial peptides, consisting of 46 amino acid residues, first isolated from the European edible frog, P. kl. 
esculentus [8-9]. After these reports, more families of peptides were described from this species, including 
bradykinins, brevinins and temporins. This edible frog species, P. kl. esculentus, which is a hybridogenetic 
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hybrid between Rana ridibunda and Rana lessonae, is a complex and special species for study, which not only 
represents a rich source for novel peptide discovery but also represents an important model for studying 
amphibian evolution [10]. 
Here, we report the structures of several skin secretion peptides identified in P. kl. esculentus by use of 
“shotgun cloning” and LC/MS/MS fragmentation sequencing. Brevinin-1E and Brevinin-1Ra were previously 
reported from other closely related species of ranid, though this is the first time they have been found through 
‘shotgun’ cloning. [Asn-3, Lys-6, Phe-13] 3-14-bombesin (NLGKQWAVGHFM) was identified by molecular 
mass fingerprinting of reverse phase HPLC fractions of skin secretion and its structure confirmed following 
LC/MS. Brevinin-2Tb and Esculentin-2b were obtained in previous studies of this species, however, some 
primary structural modifications in precursors were found here and this may arise through natural variation 
between individual specimens or discrete populations. This molecular natural selection provides a good basis for 
the diversity in chemical structure that may eventually lead to functional development and/or optimisation. 
2. Materials and methods 
2.1 Preparation of P. kl. esculentus skin secretion 
Pelophylax kl. esculentus (n=30) obtained from a local herpetological supplier were all adults and secretion 
harvesting was performed in the field after which frogs were released. Gentle transdermal electrical stimulation 
(5V; 3ms pulses) for 30s was employed to collect skin secretions from the frog’s dorsal skin. The stimulated 
secretions washed by deionised water from the skin were snap-frozen in liquid nitrogen and lyophilised, which 
was following stored at −20° C for further analysis. 
2.2“Shotgun” cloning of P. kl. esculentus skin secretion-derived cDNA 
Five milligrams of lyophilised skin secretion were dissolved in 1ml of cell lysis/mRNA protection buffer 
supplied by Dynal Biotec, UK. By the use of magnetic oligo-dT beads as described by the manufacturer (Dynal 
Biotec, UK), polyadenylated mRNA was isolated and subsequently subjected to 5′- and 3′-rapid amplification of 
cDNA ends (RACE) procedures to obtain full-length peptide precursor nucleic acid sequence data using a 
Switching Mechanism At 5' end of RNA Transcript (SMART) -RACE kit (Clontech, UK) essentially. Briefly, 
the 3′-RACE reactions employed four pairs of primers, OL-Signal(5′-
CCCAAAGATGTTCACCTTGAAGAAA-3′)/NUP, RA-Signal(5′-ATGTTCACCATGAAGAAATC-3′)/RA-
AS(5′-CTATCCCACATCAGGAGACTTTCC-3′), OL-Signal/C12-OAS(5′-
GACATCTGTTGTGCATTCAGCTAA-3′) and OS-1(5′-GTTCACCATGAAGAAATCCCTGTTACT-3′)/NUP. 
These primers were designed to highly-conserved domains of the 5′-untranslated regions of previously 
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characterized peptide precursor cDNAs from ranid frogs. Based on a pGEM-T vector system (Promega 
Corporation), the gel purified 3′-RACE reactions were cloned and then sequenced by an ABI 3730 automated 
sequencer.   
2.3 Identification and structural analysis of novel peptides 
Five milligrams of lyophilised skin secretion were dissolved in 0.5 ml of 0.05/99.5 (v/v) trifluoroacetic acid 
(TFA)/water and centrifuged for clarification of microparticulate. A linear gradient formed from trifluoroacetic 
acid (TFA)/water; 0.1:99.9 (v/v), to trifluoroacetic acid (TFA)/water/acetonitrile; 0.1:19.9:80.0 (v/v/v) were 
pumped through a 1cm×25cm Jupiter 00G4052 semi-preparative C-5 reverse phase column (Phenomenex, UK) 
attached to a Cecil Adept Binary HPLC system (Adept Technology, Inc. USA) in 240 min at a flow rate of 1 
ml/min for elution of collected supernatant. Samples (100μl) were removed from each fraction in triplicate, 
lyophilised and stored at −20°C prior to bioactivity assays. The fractions that exhibited specified activity were 
subjected to Matrix-Assisted Laser Desorption/ Ionization Time of Flight Mass Spectrometry (MALDI-TOF) 
MS analysis using a Perseptive Biosystems Voyager DE instrument (Framingham, MA, USA) in positive ion 
mode and α-cyano-4-hydroxycinnamic acid as matrix. Internal mass calibration of the instrument with peptide 
standards established the accuracy of mass determinations as ±0.01%. 
2.4 Tandem mass spectrometry sequencing 
20 μl of the diluted skin secretion fraction pumped directly onto an analytical HPLC column (Phenomenex 
C-18; 4.6 × 150 mm) connected to an LCQ Fleet ESI ion trap mass spectrometer (Thermo Fisher, San Jose, CA, 
USA) in the positive detection mode. The linear elution gradient was formed from 0.1/99.9 (v/v) trifluoroacetic 
acid (TFA)/water to trifluoroacetic acid (TFA)/water/acetonitrile; 0.1:19.9:80.0 (v/v/v) in 135 min at a flow rate 
20 μl/min. Mass analysis was performed in a positive ion mode with acquired spectra in the range of m/z 500–
2000 with N50% relative intensity during HPLC-MS. Parameters for electrospray ionization ion-trap mass 
spectrometry (ESI/MS) were: spray voltage +4.5 kV, drying gas temperature 320 °C, drying gas flow 200 
μl/min, and maximum accumulation time – for the ion trap – 350 ms. The first mass analysis was performed in 
full scan mode, then peptide ions with N50% relative intensity were selected for fragmentation by collision 
induced dissociation (CID), to generate b and y ions that were detected in a second mass analysis. The 
instrument was controlled by Xcalibur software (Thermo, USA) and data analysis was performed using 
Proteome Discover 1.0 (Thermo, USA). Sequest™ algorithm was employed to compare the acquired fragment 
ion profiles with the theoretical fragment ions generated from a FASTA database. 
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3. Result 
3.1 Molecular cloning of novel peptide precursor-encoding cDNA 
Brevinin-1, Brevinin-2, Esculentin-1, Esculentin-2 and bombesin, these five different families of bioactive 
peptide precursors were repeatedly cloned from the cDNA library constructed from the skin secretion of P. kl. 
esculentus using the primers that were designed from previously characterised ranid frog peptide precursor 
cDNAs. The nucleotide of open-reading frames of the cloned precursor transcripts and its translated amino acid 
sequences are illustrated in Fig 1. The deduced single copies of mature peptide sequences located at the C-
terminal regions were analysed using the Basic Local Alignment Search Tool (BLAST) program of the US 
National Centre for Biotechnology information (NCBI) on-line portal.   
Brevinin-1Ra and Brevinin-1E were previously obtained from the skin secretion of the marsh frog, Rana 
ridibundus, by high-performance liquid chromatography/ tandem mass spectrometry (HPLC/MS/MS) analysis, 
though according to the disadvantages of MS/MS, Lys/Gln and Ile/Leu, were not resolved as they are too close 
or indeed identical in molecular masses. This is the first time these two precursor sequences have been 
confirmed using a molecular cloning method and their first identification in P. kl. esculentus. Brevinin-2Tbe, 
belonging to the Brevinin-2 subfamily, has a precursor that displays significantly structural similarity to 
Brevinin-2Tb (98%) and Brevinin-2Ei (94%). The mature peptide sequence of Esculentin-2c, which belongs to 
Esculentin-2 subfamily, displays 95% identify with Esculentin-2b, where there are only two amino acids 
differences among total 37 amino acids that are Lys13 and Met29 that take the place of Ala13 and Ile29 of 
Esculentin-2b. All mature peptide sequences obtained in this study are compared with the most similar peptides 
in the database in Fig 2. Esculentin-2c and Brevinin-2Tbe has become available in Genbank Nucleotide 
Sequence Database though the accession code KT437660 and KT437661. 
3.2 Identification and structural analyses of [Asn-3, Lys-6, Phe-13] 3-14-bombesin in reverse phase HPLC 
fractions of P. kl. esculentus skin secretion  
[Asn-3, Lys-6, Phe-13] 3-14-bombesin was identified in the reverse phase HPLC fractions based on its singly-
charged and mono-isotopic molecular mass [M + H]1+ m/z of 1386.59 as determined by Matrix-Assisted Laser 
Desorption/ Ionization Time of Flight (MALDI-TOF) mass spectrometric analysis and confirmed by LCQ ESI 
MS full scan. The spectrum corresponding to the primary structure of [Asp-3, Lys-6, Phe-13] 3-14-bombesin ( 
Fig 3) was produced by entrapment of the doubly-charged ion of this peptide by the ion trap of the LCQ Fleet 
mass spectrometer with further determined using MS/MS fragmentation.4. Discussion 
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In order to combat the increasing emergency of multiple drug-resistances in pathogenic bacteria all over 
world, scientists have been searching both chemical and natural product compound libraries for new lead 
compounds. The unique evolution of the amphibian host defence strategy not only provides a huge variety of 
bioactive peptides, but also their living environments and solutions to problems can supply clues for the 
development of possible therapeutics of medical or veterinary significance [11]. Amphibians are described as 
cold-blooded vertebrates covered by a skin that is rich in secretory glands [12-14] and it is these glands that 
manufacture, store and release the plethora of bioactive compounds. Members of the Ranidae (‘true frogs’) are 
such a good example that their skin secretions are constructed by a diverse range of bioactive compounds 
besides antimicrobial peptides. Generally, there are 10-20 unique peptides produced in one species which could 
have differences in sizes, sequences and spectrum of actions, etc., among frogs from different families, genera 
and species. Moreover, even members of the same species inhabiting different zones are able to create special 
peptides due to natural selection, such as Esculentin-2c that we report here. This phenomenon could explain 
why no two species have been found so far to produce the same antimicrobial peptides [2]. Such various 
peptides could be regarded as lead compounds as their potencies could be enhanced by chemical modification to 
promote the development of new drugs. 
The European edible frog, P. kl. esculentus, is a hybrid originally produced between female R.ridibunda 
and male R.lessonae, whereas the lineages of P. kl. esculentus are maintained by mating females of P. kl. 
esculentus with males of R.lessonae [15]. Studies on the skin peptide precursor sequences of P. kl. esculentus by 
molecular cloning technology has indicated one common cDNA-encoding precursor structure, which has a 
highly conserved N-terminal preproregioin composed of a 22 residues long hydrophobic signal peptide, either 
intra- or inter-specifically, and an 16-25 residues acidic propiece that is followed by a typical prohormone 
processing signal Lys-Arg.  Finally, a single copy of the mature peptide is encoded at the carboxyl terminus of 
the precursor sequence.  
Compared with anti-bacterial mechanisms of conventional antibiotics that select intracellular targets and 
cellular processes such as DNA replication, protein and cell wall synthesis, the AMPs are able to rapidly disrupt 
the bacterial membranes directly with low selectivity making resistance evolution more unlikely. This 
fundamental mechanism of action supports AMPs as good candidates for new antibiotic drug development. 
Moreover, frogs from different species or subspecies produce various diverse antimicrobial peptides. Even the 
same species of frogs that live in different habitats or environments are capable of producing distinct repertoires 
of antimicrobial peptides to satisfy their special survival needs. The antimicrobial peptides modified by one or 
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several amino acids within their sequences could display differing sizes, net charges and hydrophobicity. 
Therefore, these analogues could exhibit differences in the spectrum of action and bioactivities to defend against 
the particular microbes that these species encounter. Esculentin-2c and Brevinin-2Tbe both have high similarity 
to the previously isolated antimicrobial peptides Esculentin-2b and Brevinin-2Tb, where just a few amino acid 
differences occur. These tiny changes inside peptide sequences, induced by either natural or artificial means, 
could create new or even higher potency antimicrobial peptides. For example, Brevinin-1BYa recently obtained 
from North American Foothill yellow-legged frogs, Rana boylii, belonging to the Brevinin-1 family, has broad-
spectrum antibacterial and antifungal properties [16]. New research has discovered one portion of the residues 
of the full-length antimicrobial peptide sequences could also be the templates of new antibiotic development as 
they have potent abilities against many pathogens. Take Esculentin (1-21) for example, which is the N-terminal 
1-21 region of the esculentin-1a isolated from P. kl. esculentus, exhibits the high antimicrobial activities against 
the most common mastitis-causing microbes in cattle [17,18]. 
Bombesin and its related homologues, which take part in the synthesis of neuropeptides and hormones and 
have widespread effects on the gastrointestinal tract and central nervous system’ secretory functions, are widely 
distributed in the frog skin secretions, though its analogues obtained from P. kl. esculentus have been rarely 
reported before. [Asn-3, Lys-6, Phe-13] 3-14-bombesin, originally identified from the Marsh frog, Rana 
ridibunda, has an active core of eight amino acids at the C-terminus that is responsible for binding  to receptors 
[19-20], and here, this peptide has been characterised in the skin secretion of P. kl. esculentus using an LC/MS 
technique. It was exciting to find another neuropeptide family, bombesin, represented in P. kl. esculentus skin in 
addition to bradykinin, that provides scientists with a better understanding of the bio-actions of the skin 
secretion of this species and an additional choice for neuropeptide study selection.  
The skin secretions of P. kl. esculentus are a rich source of antimicrobial peptides that have high potency 
against bacteria including many pathogenic strains [16,21]. As more studies are performed on the isolation of 
peptides from amphibians, new peptides will be discovered and more additional bioactivities will be found that 
could supply great clues to improve therapeutic agents and drug development for human healthcare. Due to the 
development of molecular techniques, especially those that can provide comparisons of the nucleotide 
sequences of orthologous genes, new phylogenetic analysis of relationships between species has been made 
possible as an addition to the classic approach of using such aspects as the fossil record and morphological 
characteristics. Moreover, this improved understanding of amphibian evolutionary history should be more 
accurate, easier to understand and hence be more commonly accepted [22, 23]. 
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Data deposition footnote 
 
The nucleotide sequence of the Brevinin-2Tbe and Esculentin-2c precursors from the skin secretion of the 
European edible frog, Pelophylax kl. esculentus, have been deposited in the EMBL Nucleotide Sequence 
Database under the accession code KT437661 and KT437660. 
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Legends to Figures 
Fig 1. Nucleotide sequence and open reading frame amino acid translation of full length prepro cDNA from the 
skin secretion of the European edible frog Rana esculenta encoding brevinin-1E (a), brevinin-1Ra (b), brevinin-
2Ec (c), Esculentin-2c (d), brevinin-Ei (e), brevinin-2Tbe (f) . The double underlined sequence is the putative 
signal peptide. The single underlined sequence is the sequence of the mature peptide and the stop codon is 
indicated by an asterisk. 
Fig 2. (A) A comparison of the primary structures of the Brevinin-1 and -2 related peptides isolated from frogs 
of the R.esculenta complex with those of brevinin-1 and-2 from R.brevipoda porsa. (B) Comparison of the 
amino acid sequences of Esculentin-1 and -2 related peptides from skin secretions of R.esculenta. The 
disulphide bonds formed by the identical cysteine residues were underlined. Gaps (---) were introduced to 
maximise the identities. Amino acids common to all the peptides in each of the two subfamilies present in skin 
secretions of R.esculenta are in shadow. 
Fig 3. (A) LCQ ESI Electrospray (LCQ) MS/MS spectrum of putative bombesin-related peptide. (B) Predicted 
b- and y-ion MS/MS fragment ion series (singly- and doubly- charged) of [Asn-3, Lys-6, Phe-13] 3-14-
bombesin. Observed ions are indicated in black typeface. 
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Table 1.  Skin secretion peptides isolated from Rana esculenta 
Name Sequence M.W. Ref. 
Brevinin-1E FLPLLAGLAANFLPKIFCKITRKC 2676 8 
Brevinin-1Ea FLPAIFRMAAKVVPTIICSITKKC 2649 8 
Brevinin-1Eb VIPFVASVAAEMQHVYCAASRKC 2480 8 
Brevinin-1Ecb FLPLLAGLAANFFPKIFCKITRKC 2712 8 
Brevinin-1Ra VIPFVASVAAEMMQHVYCAASRRC 2640 19, 20 
Brevinin-2E GIMDTLKNLAKTAGKGALQSLLNKASCKLSGQC 3361 8 
Brevinin-2Ea GILDTLKNLAISAAKGAAQGLVNKASCKLSGQC 3242 8 
Brevinin-2Eb GILDTLKNLAKTAGKGALQGLVKMASCKLSGQC 3316 8 
Brevinin-2Ec GILLDKLKNFAKTAGKGVLQSLLNTASCKLSGQC 3519 8 
Brevinin-2Ed GILDSLKNLAKNAGQILLNKASCKLSGQC 2999 8 
Brevinin-2Ef GIMDTLKNLAKTAGKGALQSLVKMASCKLSGQC 3365 25 
Brevinin-2Eg GIMDTLKNLAKTAGKGALQSLLNHASCKLSGQC 3371 25 
Brevinin-2Eh GIMDTLKNLAKTAGKGALQSLLNHASCKLSKQC 3442 25 
Brevinin-2Ei GILDTLKNLAKTAGKGILKSLVNTASCKLSGQC 3309 25 
Brevinin-2Ej GIFLDKLKNFAKGVAQSLLNKASCKLSGQC 3181 24 
Brevinin-2Tbe GILDTLKNLAKTAGKGALQSLLNHASCKLSGQC 3354 - 
CPRF-Ea GLGSILGKILNVAGKVGKTIGKVADAVGNKE 3007 24 
CPRF-Eb GLGSFLKNAIKIAGKVGSTIGKVADAIGNKE 3055 24 
CPRF-Ec GLGSFFKNAIKIAGKVGSTIGKVADAIGNKE 3091 24 
Esculentin-1 GIFSKFGRKKIKNLLISGLKNVGKEVGMDVVRTGIDIAG
CKIKGEC 
4884 8 
Esculentin-1a GIFSKLAGKKIKNLLISGLKNVGKEVGMDVVRTGIDIA
GCKIKGEC 
4799 8 
Esculentin-1b GIFSKLAGKKLKNLLISGLKNVGKEVGMDVVRTGIDIA
GCKIKGEC 
4802 8 
Esculentin-1c GIFSKLAGKKIKNLLISGLKNIGKEVGMDVVRTGIDIAG
CKIKGEC 
4813 8 
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Esculentin-2a GILSLVKGVAKLAGKGLAKEGGKFGLELIACKIAKQC 3711 8 
Esculentin-2b GIFSLVKGAAKLAGKGLAKEGGKFGLELIACKIAKQC 3717 8 
Esculentin-2c GIFSLVKGAAKLLGKGLAKEGGKFGLELMACKIAKQC 3778 - 
Ranacyclin E SAPRGCWTKSYPPKPCK 1904 26 
Temporin-1Ec FLPVIAGLLSKLF 1417 9,24 
Peptides A1 FLPAIAGILSQLF 1388 9,24 
Peptides B9 FLPLIAGLLGKLF 1400 9,24 
Temproin-1Ee FLPVIAGVLSKLF 1402 33 
Temporin-1Re FLPGLLAGLL-NH2 1012 33 
[Asp3, Lys6, 
Phe13]3-14-
bombesin 
NLGKQWAVGHFM 1386 20, 29, 
32 
kunitzin-RE  AAKIILNPKFRCKAAFC 
 
1893 20,27,28 
Arg0, Trp5, 
Leu8-bradykinin 
RRPPGWSPLR   1221 29, 30, 
31, 32 
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Fig 1. 
(a) 
  M  F  T   M  K  K  S   M  L  L   L  F  F   L  G  T  I  
    1 ATGTTCACCA TGAAGAAATC CATGTTACTC CTTTTCTTCC TTGGGACCAT 
 TACAAGTGGT ACTTCTTTAG GTACAATGAG GAAAAGAAGG AACCCTGGTA 
   N  L  S   L  F  E   E  E  R  D   A  D  E   E  E  R   
   51 CAACTTATCT CTTTTTGAGG AAGAGAGAGA TGCCGATGAA GAAGAAAGAA 
 GTTGAATAGA GAAAAACTCC TTCTCTCTCT ACGGCTACTT CTTCTTTCTT 
 R  D  N  P   D  E  S   E  V  E   V  E  K  R   F  L  P 
  101 GAGACAATCC AGATGAAAGT GAAGTTGAAG TGGAAAAACG ATTTCTTCCA 
 CTCTGTTAGG TCTACTTTCA CTTCAACTTC ACCTTTTTGC TAAAGAAGGT 
  L  L  A   G  L  A  A   N  F  L   P  K  I   F  C  K  I  
  151 TTGTTGGCAG GTCTGGCTGC TAATTTCTTG CCGAAAATAT TTTGTAAAAT 
 AACAACCGTC CAGACCGACG ATTAAAGAAC GGCTTTTATA AAACATTTTA 
   T  R  K   C  * 
  201 AACCAGAAAA TGTTGAAACT TTGGAATTGG AAATCATCTG ATGTGGAAAA 
 TTGGTCTTTT ACAACTTTGA AACCTTAACC TTTAGTAGAC TACACCTTTT 
  251 TCATTTAGCT AAATACACAT CAGATGTCTT ATAAAAAATA AAGATATTGC 
 AGTAAATCGA TTTATGTGTA GTCTACAGAA TATTTTTTAT TTCTATAACG 
  301 ATACAGAATA TAAAAAAAAA AAAAAAAAAA AAAAAAT 
 TATGTCTTAT ATTTTTTTTT TTTTTTTTTT TTTTTTA 
(b) 
  M  F  T   M  K  K  S   M  L  L   L  F  F   I  G  T  I  
    1 ATGTTCACCA TGAAGAAATC CATGTTACTC CTTTTCTTTA TTGGGACCAT 
 TACAAGTGGT ACTTCTTTAG GTACAATGAG GAAAAGAAAT AACCCTGGTA 
   N  L  S   L  C  E   E  E  R  A   A  D  E   E  E  R   
   51 CAACTTATCT CTCTGTGAGG AAGAGAGAGC TGCTGATGAG GAAGAAAGAA 
 GTTGAATAGA GAGACACTCC TTCTCTCTCG ACGACTACTC CTTCTTTCTT 
 R  D  D  Q   A  E  T   E  V  E   V  E  K  R   V  I  P 
  101 GAGATGATCA AGCAGAAACA GAGGTTGAGG TGGAAAAACG AGTTATACCA 
 CTCTACTAGT TCGTCTTTGT CTCCAACTCC ACCTTTTTGC TCAATATGGT 
  F  V  A   S  V  A  A   E  M  M   Q  H  V   Y  C  A  A  
  151 TTTGTGGCAA GTGTGGCTGC CGAAATGATG CAGCACGTGT ATTGTGCAGC 
 AAACACCGTT CACACCGACG GCTTTACTAC GTCGTGCACA TAACACGTCG 
   S  R  R   C  * 
  201 TTCCAGAAGA TGTTAAATTA AATTGGAAAT CATCTGCTGT GGAAAATCAT 
 AAGGTCTTCT ACAATTTAAT TTAACCTTTA GTAGACGACA CCTTTTAGTA 
  251 TTAGCTAAAT GCTAAATGTC TTATAAAAAA ATAAAGTTGT TGCATACACT 
 AATCGATTTA CGATTTACAG AATATTTTTT TATTTCAACA ACGTATGTGA 
  301 GTTACAAAAA AAAAAAAAAA AAAAAAAAAA AAAAAA 
 CAATGTTTTT TTTTTTTTTT TTTTTTTTTT TTTTTT 
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 (c) 
  M  F  T   M  K  K  S   L  L  L   L  F  F   L  G  T  I 
    1 ATGTTCACCA TGAAGAAATC CCTGTTACTC CTTTTCTTTC TTGGGACCAT 
 TACAAGTGGT ACTTCTTTAG GGACAATGAG GAAAAGAAAG AACCCTGGTA 
   S  L  S   L  C  E   E  E  R  N   A  D  E   D  D  G   
   51 CTCCTTATCT CTCTGTGAGG AAGAGAGAAA TGCTGATGAG GATGATGGGG 
 GAGGAATAGA GAGACACTCC TTCTCTCTTT ACGACTACTC CTACTACCCC 
 E  M  T  E   E  V  K   R  G  I   L  L  D  K   L  K  N 
  101 AAATGACAGA GGAAGTAAAA AGAGGTATCC TCCTGGATAA GCTGAAGAAT 
 TTTACTGTCT CCTTCATTTT TCTCCATAGG AGGACCTATT CGACTTCTTA 
  F  A  K   T  A  G  K   G  V  L   Q  S  L   L  N  T  A  
  151 TTTGCCAAGA CAGCAGGCAA AGGTGTGCTC CAGAGTCTGC TGAATACGGC 
 AAACGGTTCT GTCGTCCGTT TCCACACGAG GTCTCAGACG ACTTATGCCG 
   S  C  K   L  S  G   Q  C  * 
  201 ATCTTGTAAA CTTTCTGGAC AATGTTAAAA CATGAATTGG AAGTCATTTG 
 TAGAACATTT GAAAGACCTG TTACAATTTT GTACTTAACC TTCAGTAAAC 
  251 ATGCAGAATA TCATTTAGCT AAATGCTAAA TGTCTGATAA AAAATAAAAA 
 TACGTCTTAT AGTAAATCGA TTTACGATTT ACAGACTATT TTTTATTTTT 
  301 GATCACACAA AAAAAAAAAA AAAAAAAAAA AAAAAAAA 
 CTAGTGTGTT TTTTTTTTTT TTTTTTTTTT TTTTTTTT 
(d) 
           M   K  K  S  L  L   L  L   F  F  I   G  T   I   
    1 GTTCACCATG AAGAAATCCC TGTTACTCCT TTTCTTTATT GGGACCATCT 
 CAAGTGGTAC TTCTTTAGGG ACAATGAGGA AAAGAAATAA CCCTGGTAGA 
 S  L  S  L   C  Q  E   E  R  G   A  D  G  E   E  E  G 
   51 CCTTATCTCT CTGTCAGGAA GAGAGAGGCG CCGATGGAGA AGAGGAAGGG 
 GGAATAGAGA GACAGTCCTT CTCTCTCCGC GGCTACCTCT TCTCCTTCCC 
  E  E  M   K  R  G  I   F  S  L   V  K  G   A  A  K  L  
  101 GAAGAAATGA AAAGAGGTAT TTTCTCGCTA GTCAAAGGTG CAGCCAAGCT 
 CTTCTTTACT TTTCTCCATA AAAGAGCGAT CAGTTTCCAC GTCGGTTCGA 
   L  G  K   G  L  A   K  E  G  G   K  F  G   L  E  L   
  151 ACTGGGCAAA GGTTTGGCCA AGGAAGGGGG CAAGTTTGGG CTGGAGCTTA 
 TGACCCGTTT CCAAACCGGT TCCTTCCCCC GTTCAAACCC GACCTCGAAT 
 M  A  C  K   I  A  K   Q  C  * 
  201 TGGCTTGTAA AATTGCAAAA CAATGTTAAA TCTTCAATTG GAGGTCATCT 
 ACCGAACATT TTAACGTTTT GTTACAATTT AGAAGTTAAC CTCCAGTAGA 
  251 GATGTGGAAT ATCATTTAGC AAAATGCTAA TTGTCTAATA AAAAAAATAG 
 CTACACCTTA TAGTAAATCG TTTTACGATT AACAGATTAT TTTTTTTATC 
  301 CAATGTCACA AAAAAAAAAA AAAAAAAAAA AAAA 
 GTTACAGTGT TTTTTTTTTT TTTTTTTTTT TTTT 
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(e) 
  M  F  T   L  K  K  S   L  L  L   F  F  F   L  G  T  I   
    1 ATGTTCACCT TGAAGAAATC CCTGTTACTC TTTTTCTTTC TTGGGACCAT 
 TACAAGTGGA ACTTCTTTAG GGACAATGAG AAAAAGAAAG AACCCTGGTA 
   S  L  S   L  C  Q   E  E  R  N   A  D  E   D  D  G   
   51 CTCCTTATCT CTCTGTCAGG AAGAGAGAAA TGCTGATGAG GACGATGGGG 
 GAGGAATAGA GAGACAGTCC TTCTCTCTTT ACGACTACTC CTGCTACCCC 
 E  M  T  E   E  E  K   R  G  I   L  D  T  L   K  N  L 
  101 AAATGACAGA GGAAGAAAAA AGAGGTATCC TGGATACGCT GAAGAATTTA 
 TTTACTGTCT CCTTCTTTTT TCTCCATAGG ACCTATGCGA CTTCTTAAAT 
  A  K  T   A  G  K  G   I  L  K   S  L  V   N  T  A  S  
  151 GCCAAGACAG CAGGCAAAGG TATACTGAAG AGTCTGGTGA ATACGGCATC 
 CGGTTCTGTC GTCCGTTTCC ATATGACTTC TCAGACCACT TATGCCGTAG 
   C  K  L   S  G  Q   C  * 
  201 TTGTAAACTT TCTGGACAAT GCTAAAACAT GAATTGGAAG TCATTTGATG 
 AACATTTGAA AGACCTGTTA CGATTTTGTA CTTAACCTTC AGTAAACTAC 
  251 CAGCATATCA TTTAGCTAAA TACTAAATGT CTGATAAAAA ATAAAAATAT 
 GTCGTATAGT AAATCGATTT ATGATTTACA GACTATTTTT TATTTTTATA 
  301 CACATGAAAA AAAAAAAAAA AAAAAAAAAA AAAA 
 GTGTACTTTT TTTTTTTTTT TTTTTTTTTT TTTT 
(f) 
  M  F  T   L  K  K  S   L  L  L   F  F  F   L  G  T  I  
    1 ATGTTCACCT TGAAGAAATC CCTGTTACTC TTTTTCTTTC TTGGGACCAT 
 TACAAGTGGA ACTTCTTTAG GGACAATGAG AAAAAGAAAG AACCCTGGTA 
   S  L  S   L  C  Q   E  E  R  N   A  D  E   D  D  G   
   51 CTCCTTATCT CTCTGTCAGG AAGAGAGAAA TGCTGATGAG GACGATGGGG 
 GAGGAATAGA GAGACAGTCC TTCTCTCTTT ACGACTACTC CTGCTACCCC 
 E  M  T  E   E  E  K   R  G  I   L  D  T  L   K  N  L 
  101 AAATGACAGA GGAAGAAAAA AGAGGTATCC TGGATACGCT GAAGAATTTA 
 TTTACTGTCT CCTTCTTTTT TCTCCATAGG ACCTATGCGA CTTCTTAAAT 
  A  K  T   A  G  K  G   A  L  Q   S  L  L   N  H  A  S  
  151 GCCAAGACAG CAGGCAAAGG TGCGCTCCAG AGTCTGCTGA ATCATGCATC 
 CGGTTCTGTC GTCCGTTTCC ACGCGAGGTC TCAGACGACT TAGTACGTAG 
   C  K  L   S  G  Q   C  * 
  201 TTGTAAACTT TCTGGACAAT GTTAAAACAT GAATTGGAAG TCATTTGATG 
 AACATTTGAA AGACCTGTTA CAATTTTGTA CTTAACCTTC AGTAAACTAC 
  251 CAGAATATCA TTTAGCTAAA TACTAAATGT CTGATAAAAA ATAAATAGAT 
 GTCTTATAGT AAATCGATTT ATGATTTACA GACTATTTTT TATTTATCTA 
  301 CAC 
 GTG 
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Fig 2. 
(a) 
                    1                     24 
  Brevinin-1    (1) FLPVLAGIAAKVVPALFCKITKKC 
  Brevinin-1E   (1) FLPLLAGLAANFLPKIFCKITRKC 
  Brevinin-1Ea  (1) FLPAIFRMAAKVVPTIICSITKKC 
  Brevinin-1Eb  (1) VIPFVASVAAEMQ-HVYCAASRKC 
  Brevinin-1Ecb (1) FLPLLAGLAANFFPKIFCKITRKC 
  Brevinin-1Ra  (1) VIPFVASVAAEMMQHVYCAASRRC 
 
 
                     1                               34 
  Brevinin-2    (1) -GLLDSLKGFAATAGKGVLQSLLSTASCKLAKTC 
  Brevinin-2E   (1) -GIMDTLKNLAKTAGKGALQSLLNKASCKLSGQC 
  Brevinin-2Ea  (1) -GILDTLKNLAISAAKGAAQGLVNKASCKLSGQC 
  Brevinin-2Eb  (1) -GILDTLKNLAKTAGKGALQGLVKMASCKLSGQC 
  Brevinin-2Ec  (1) GILLDKLKNFAKTAGKGVLQSLLNTASCKLSGQC 
  Brevinin-2Ed  (1) -GILDSLKNLAKNAG----QILLNKASCKLSGQC 
  Brevinin-2Ef  (1) -GIMDTLKNLAKTAGKGALQSLVKMASCKLSGQC 
  Brevinin-2Eg  (1) -GIMDTLKNLAKTAGKGALQSLLNHASCKLSGQC 
  Brevinin-2Eh  (1) -GIMDTLKNLAKTAGKGALQSLLNHASCKLSKQC 
  Brevinin-2Ei  (1) -GILDTLKNLAKTAGKGILKSLVNTASCKLSGQC 
  Brevinin-2Ej  (1) GIFLDKLKNFAK----GVAQSLLNKASCKLSGQC 
  Brevinin-2Tbe (1) –GILDTLKNLAKTAGKGALQSLLNHASCKLSGQC 
 
 
 
 
(b) 
                    1                                             48 
Esculentin-1    (1) GIFSKFGRKKIKNLLISGLKNVGKEVGMD--VVRTGIDIAGCKIKGEC 
Esculentin-1a   (1) GIFSKLAGKKIKNLLISGLKNVGKEVGMD--VVRTGIDIAGCKIKGEC 
Esculentin-1b   (1) GIFSKLAGKKLKNLLISGLKNVGKEVGMETDVVRTGIDIAGCKIKGEC 
Esculentin-1c   (1) GIFSKLAGKKIKNLLISGLKNIGKEVGMD--VVRTGIDIAGCKIKGEC 
     
 
 
                    1                                  37 
Esculentin-2a   (1) GILSLVKGVAKLAGKGLAKEGGKFGLELIACKIAKQC 
Esculentin-2b   (1) GIFSLVKGAAKLAGKGLAKEGGKFGLELIACKIAKQC 
Esculentin-2c   (1) GIFSLVKGAAKLLGKGLAKEGGKFGLELMACKIAKQC 
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Fig 3.
 
 
#1 b(1+) b(2+) Seq. y(1+) y(2+) #2 
1 115.05021 58.02874 N     12 
2 228.13428 114.57078 L 1273.65109 637.32918 11 
3 285.15575 143.08151 G 1160.56702 580.78715 10 
4 413.25072 207.12900 K 1103.54555 552.27641 9 
5 541.30930 271.15829 Q 975.45058 488.22893 8 
6 727.38862 364.19795 W 847.39200 424.19964 7 
7 798.42574 399.71651 A 661.31268 331.15998 6 
8 897.49416 449.25072 V 590.27556 295.64142 5 
9 954.51563 477.76145 G 491.20714 246.10721 4 
10 1091.57454 546.29091 H 434.18567 217.59647 3 
11 1238.64296 619.82512 F 297.12676 149.06702 2 
12     M 150.05834 75.53281 1 
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